all-antibody

Malnutrition-Inflammation Complex Syndrome In Dialysis Patients

Robust affiliation between malnutrition, irritation, and atherosclerosis in power renal failure.

Background

Atheroscleroticcardiovascular illness and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

METHODS

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion. The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

 

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

all-antibody
all-antibody

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

GPR61 Antibody

DF2810-200ul 200ul
EUR 350

GPR61 Antibody

DF2755 100ul
EUR 280
Description: Human,Mouse

GPR61 Antibody

DF2810 100ul
EUR 280
Description: Human,Mouse

GPR61 Conjugated Antibody

C44933 100ul
EUR 476.4

GPR61 Polyclonal Antibody

ABP58695-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody

ABP58695-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody

ABP58695-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody

ES11477-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Polyclonal Antibody

ES11477-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Polyclonal Antibody

E11-202531 100ug/100ul
EUR 225
Description: Available in various conjugation types.

GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61)

SC106692 10 µg Ask for price

GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61)

SC317735 10 µg Ask for price

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody

20-abx147479
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody

abx147480-100ug 100 ug
EUR 526.8

Polyclonal GPR61 Antibody (C-Terminus)

APR16588G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (C-Terminus)

APR16589G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (N-Terminus)

APR16592G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (N-Terminus). This antibody is tested and proven to work in the following applications:

GPR61 Recombinant Protein (Rat)

RP203447 100 ug Ask for price

GPR61 Recombinant Protein (Human)

RP013882 100 ug Ask for price

GPR61 Recombinant Protein (Mouse)

RP139673 100 ug Ask for price

Polyclonal GPR61 Antibody (Cytoplasmic Domain)

APR16590G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (Extracellular Domain)

APR16591G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

GPR61 (GFP-tagged) - Human G protein-coupled receptor 61 (GPR61)

RG209672 10 µg Ask for price

Gpr61 (untagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug)

MC216046 10 µg Ask for price

Human GPR61 Protein Lysate 20ug

IHUGPR61PLLY20UG each
EUR 213
Description: Human GPR61 Protein Lysate 20ug

OCOA07698-20UG - GPR61 Protein Lysate

OCOA07698-20UG 20ug
EUR 169

Gpr61 (GFP-tagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug)

MG216498 10 µg Ask for price

GPR61 (Myc-DDK-tagged)-Human G protein-coupled receptor 61 (GPR61)

RC209672 10 µg Ask for price

Gpr61 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 61 (Gpr61)

MR216498 10 µg Ask for price

GPR61 Rabbit Polyclonal (N-Terminus) Antibody

TA316841 50 µg Ask for price

GPR61 Rabbit Polyclonal (C-Terminus) Antibody

TA316842 50 µg Ask for price

GPR61 Rabbit Polyclonal (C-Terminus) Antibody

TA316843 50 µg Ask for price

Gpr61 (untagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), (10 ug)

RN213131 10 µg Ask for price

GPR61 Rabbit Polyclonal (Cytoplasmic Domain) Antibody

TA316845 50 µg Ask for price

GPR61 Rabbit Polyclonal (Extracellular Domain) Antibody

TA316844 50 µg Ask for price

ARP95145_P050-25UL - GPR61 Antibody - N-terminal region

ARP95145_P050-25UL 25ul
EUR 99

GPR61 Protein Vector (Rat) (pPM-C-HA)

PV271268 500 ng
EUR 723.6

Gpr61 (Myc-DDK-tagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), (10 ug)

RR213131 10 µg Ask for price

GPR61 Protein Vector (Rat) (pPB-C-His)

PV271266 500 ng
EUR 723.6

GPR61 Protein Vector (Rat) (pPB-N-His)

PV271267 500 ng
EUR 723.6

GPR61 Protein Vector (Rat) (pPM-C-His)

PV271269 500 ng
EUR 723.6

GPR61 Protein Vector (Human) (pPM-C-HA)

PV018511 500 ng
EUR 394.8

GPR61 Protein Vector (Mouse) (pPM-C-HA)

PV186236 500 ng
EUR 723.6

GPR61 Protein Vector (Human) (pPB-C-His)

PV018509 500 ng
EUR 394.8

GPR61 Protein Vector (Human) (pPB-N-His)

PV018510 500 ng
EUR 394.8

GPR61 Protein Vector (Human) (pPM-C-His)

PV018512 500 ng
EUR 394.8

GPR61 Protein Vector (Mouse) (pPB-C-His)

PV186234 500 ng
EUR 723.6

GPR61 Protein Vector (Mouse) (pPB-N-His)

PV186235 500 ng
EUR 723.6

GPR61 Protein Vector (Mouse) (pPM-C-His)

PV186237 500 ng
EUR 723.6

Lenti ORF clone of Gpr61 (mGFP-tagged) - Mouse G protein-coupled receptor 61 (Gpr61)

MR216498L4 10 µg Ask for price

Lenti ORF clone of Gpr61 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 61 (Gpr61)

MR216498L3 10 µg Ask for price

Lenti ORF clone of Gpr61 (mGFP-tagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), (10 ug)

RR213131L4 10 µg Ask for price

Protein GPR107 (GPR107) Antibody

abx233589-100ug 100 ug
EUR 661.2

Protein GPR108 (GPR108) Antibody

abx233590-100ug 100 ug
EUR 610.8

Protein GPR108 (GPR108) Antibody

20-abx324350
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Protein GPR107 (GPR107) Antibody

20-abx324945
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Protein GPR107 (GPR107) Antibody

abx031441-400ul 400 ul
EUR 627.6

Protein GPR107 (GPR107) Antibody

abx031441-80l 80 µl
EUR 343.2

Protein GPR108 (GPR108) Antibody

20-abx015294
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Lenti ORF particles, Gpr61 (GFP-tagged) - Mouse G protein-coupled receptor 61 (Gpr61), 200ul, >10^7 TU/mL

MR216498L4V 200 µl Ask for price

Lenti ORF clone of Gpr61 (Myc-DDK-tagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), (10 ug)

RR213131L3 10 µg Ask for price

Lenti ORF particles, GPR61 (mGFP-tagged) - Human G protein-coupled receptor 61 (GPR61), 200ul, >10^7 TU/mL

RC209672L2V 200 µl Ask for price

Lenti ORF particles, GPR61 (mGFP-tagged) - Human G protein-coupled receptor 61 (GPR61), 200ul, >10^7 TU/mL

RC209672L4V 200 µl Ask for price

Lenti ORF particles, Gpr61 (GFP-tagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), 200ul, >10^7 TU/mL

RR213131L4V 200 µl Ask for price

Lenti ORF particles, GPR61 (Myc-DDK tagged) - Human G protein-coupled receptor 61 (GPR61), 200ul, >10^7 TU/mL

RC209672L1V 200 µl Ask for price

Lenti ORF particles, GPR61 (Myc-DDK tagged) - Human G protein-coupled receptor 61 (GPR61), 200ul, >10^7 TU/mL

RC209672L3V 200 µl Ask for price

Lenti ORF particles, Gpr61 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 61 (Gpr61), 200ul, >10^7 TU/mL

MR216498L3V 200 µl Ask for price

Anti-GPR61 antibody

STJ192635 200 µl
EUR 236.4
Description: Unconjugated Rabbit polyclonal to GPR61

Lenti ORF particles, Gpr61 (Myc-DDK-tagged ORF) - Rat G protein-coupled receptor 61 (Gpr61), 200ul, >10^7 TU/mL

RR213131L3V 200 µl Ask for price

GPR61 siRNA

20-abx918539
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GPR61 siRNA

20-abx918540
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Protein Wntless Homolog (GPR177) Antibody

abx233601-100ug 100 ug
EUR 610.8

Integral Membrane Protein GPR137 (GPR137) Antibody

abx233594-100ug 100 ug
EUR 577.2

Integral Membrane Protein GPR175 (GPR175) Antibody

abx216260-100ug 100 ug
EUR 526.8

Integral Membrane Protein GPR180 (GPR180) Antibody

20-abx133786
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Integral Membrane Protein GPR175 (GPR175) Antibody

20-abx121124
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Integral Membrane Protein GPR175 (GPR175) Antibody

20-abx119147
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Integral Membrane Protein GPR137 (GPR137) Antibody

20-abx112628
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Integral Membrane Protein GPR137 (GPR137) Antibody

abx028020-400ul 400 ul
EUR 627.6

Integral Membrane Protein GPR137 (GPR137) Antibody

abx028020-80l 80 µl
EUR 343.2

Integral Membrane Protein GPR175 (GPR175) Antibody

20-abx015315
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Integral Membrane Protein GPR180 (GPR180) Antibody

abx034515-400ul 400 ul
EUR 627.6

Integral Membrane Protein GPR180 (GPR180) Antibody

abx034515-80l 80 µl
EUR 343.2

 

Malnutrition-inflammation complicated syndrome in dialysis sufferers: causes and penalties.

BACKGROUND

Atherosclerotic heart problems and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

 

METHODS

 

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

 

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion.

The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

 

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

  • Protein-energy malnutrition (PEM) and irritation are widespread and often concurrent in upkeep dialysis sufferers. Many components that seem to result in these 2 situations overlap, as do evaluation instruments and such standards for detecting them as hypoalbuminemia.
  • Each these situations are associated to poor dialysis end result. Low urge for food and a hypercatabolic state are amongst widespread options. PEM in dialysis sufferers has been advised to be secondary to irritation; nonetheless, the proof isn’t conclusive, and an equicausal standing and even reverse causal route is feasible.
  • Therefore, malnutrition-inflammation complicated syndrome (MICS) is an applicable time period. Attainable causes of MICS embody comorbid diseases, oxidative and carbonyl stress, nutrient loss by means of dialysis, anorexia and low nutrient consumption, uremic toxins, decreased clearance of inflammatory cytokines, quantity overload, and dialysis-related components.
  • MICS is believed to be the primary reason behind erythropoietin hyporesponsiveness, excessive charge of cardiovascular atherosclerotic illness, decreased high quality of life, and elevated mortality and hospitalization in dialysis sufferers.
  • As a result of MICS results in a low physique mass index, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a “reverse epidemiology” of cardiovascular dangers can happen in dialysis sufferers.
  • Due to this fact, weight problems, hypercholesterolemia, and elevated blood ranges of creatinine and homocysteine look like protecting and paradoxically related to a greater end result.
  • There isn’t a consensus about tips on how to decide the diploma of severity of MICS or tips on how to handle it. A number of diagnostic instruments and therapy modalities are mentioned. Profitable administration of MICS might ameliorate the cardiovascular epidemic and poor end result in dialysis sufferers.
  • Scientific trials specializing in MICS and its doable causes and penalties are urgently required to enhance poor medical end result in dialysis sufferers.

Recombinant EBV EBNA1 Protein, His, E.coli-100ug

QP11731-100ug 100ug
EUR 381.6

Recombinant EBV EBNA1 Protein, His, E.coli-500ug

QP11731-500ug 500ug
EUR 1034.4

EBV EBNA1 antibody

20-EG46 1 mg
EUR 139.2
Description: Goat polyclonal EBV EBNA1 antibody

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-1mg

QP11732-1mg 1mg
EUR 1273.2

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-100ug

QP11732-100ug 100ug
EUR 261.6

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-500ug

QP11732-500ug 500ug
EUR 795.6

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]

VAng-Lsx0111-100g 100 µg
EUR 759.6
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]

VAng-Lsx0111-500g 500 µg
EUR 2419.2
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-100g 100 µg
EUR 555.6
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-1mg 1 mg
EUR 3360
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]

VAng-2528Lsx-500g 500 µg
EUR 2040
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

EBV EBNA protein

30-AE46 200 ug
EUR 900
Description: Purified recombinant EBV EBNA protein

EBNA1 protein

30-1925 500 ug
EUR 678
Description: Purified Recombinant EBNA1 protein

EBNA1 protein (His tag)

80-1340 100 ug
EUR 289.2
Description: Purified recombinant EBNA1 protein (His tag)

Recombinant EBNA1 Protein [GST]

VAng-Lsx0122-100g 100 µg
EUR 818.4
Description: EBNA1 (EBV) (P03211) partial recombinant protein with GST tag expressed in E. coli.

EBNA1 Binding Protein 2 Protein

20-abx260778
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

abx026949-400ul 400 ul
EUR 627.6

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

abx026949-80l 80 µl
EUR 343.2

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody

20-abx123650
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

EBNA1BP2 EBNA1 Binding Protein 2 Human Recombinant Protein

PROTQ99848 Regular: 20ug
EUR 380.4
Description: Recombinant Human EBNA1BP2 produced in E. coli is a single polypeptide chain containing 329 amino acids (1-306) and having a molecular mass of 37.2kDa.;EBNA1BP2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant (E.Coli, GST tag) Epstein-Barr Virus (EBV/HHV-4) Mosaic EBNA1

RP-347 100 ug
EUR 343.2

Recombinant EBNA1 Protein [His] (1.185 mg/mL)

VAng-0610Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.185 mg/mL.

Recombinant EBNA1 Protein [His] (1.25 mg/mL)

VAng-0611Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.25 mg/mL.

Epstein-Barr Virus (HHV-4) EBNA1 Protein

20-abx260340
  • EUR 1345.20
  • EUR 560.40
  • EUR 2364.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Mouse EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit

abx389130-96tests 96 tests
EUR 1093.2

Human EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit

abx384822-96tests 96 tests
EUR 1093.2

Ebna1bp2 (GFP-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2)

MG204306 10 µg Ask for price

Ebna1bp2 (untagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2), (10ug)

MC202488 10 µg Ask for price

Recombinant EBNA1 Protein (aa 1-90, 408-498) [GST]

VAng-Lsx0128-inquire inquire Ask for price
Description: EBV NA1 (aa 1-90, 408-498) [GST], recombinant protein from E. coli.

Epstein-Barr Virus (HHV-4) Mosaic EBNA1 Protein

20-abx260113
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

EBV EBNA-3A 38 kDa

PR-1446-L 1mg
EUR 1307.3
Description: recombinant, E. coli

EBV EBNA-3A 38 kDa

PR-1446-S 200µg
EUR 326.7
Description: recombinant, E. coli

Ebna1bp2 (Myc-DDK-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2)

MR204306 10 µg Ask for price

Ebna1bp2 (untagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), (10 ug)

RN214064 10 µg Ask for price

Epstein-Barr Virus (EBV) Epstein-Bar Nuclear Antigen-1 (EBNA-1) Protein

abx061529-1mg 1 mg
EUR 2030.4

EBNA1BP2 (untagged)-Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2

SC320280 10 µg Ask for price

EBNA1BP2 (untagged)-Human EBNA1 binding protein 2 (EBNA1BP2) transcript variant 1

SC326927 10 µg Ask for price

EBV EBNA-1 IgG ELISA Kit

DEIA332 96T
EUR 618
Description: The EBVEBNA-1 IgG Antibody ELISA Test Kit has been designed for the the detectionand the quantitative determination of specific IgG antibodies against EBVEBNA-1 in serum and plasma.

EBV EBNA-1 IgA ELISA Kit

DEIA333 96T
EUR 618
Description: The EBVEBNA-1 IgA Antibody ELISA Test Kit has been designed for the the detectionand the quantitative determination of specific IgA antibodies against EBVEBNA-1 in serum and plasma.

EBV EBNA-1 IgM ELISA Kit

DEIA334 96T
EUR 618
Description: The EBVEBNA-1 IgM Antibody ELISA Test Kit has been designed for the the detectionand the quantitative determination of specific IgM antibodies against EBVEBNA-1 in serum and plasma.

EBV EBNA-1 mosaic 45 kDa

PR-1447-L 1mg
EUR 1958.7
Description: recombinant, E. coli

EBV EBNA-1 mosaic 45 kDa

PR-1447-S 200µg
EUR 489.8
Description: recombinant, E. coli

pCXWB- EBNA1

PVT10196 2 ug
EUR 361.2

Ebna1bp2 (Myc-DDK-tagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), (10 ug)

RR214064 10 µg Ask for price

EBNA1BP2 (GFP-tagged) - Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 1

RG228292 10 µg Ask for price

EBNA1BP2 (GFP-tagged) - Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2

RG200250 10 µg Ask for price

Lenti ORF clone of Ebna1bp2 (mGFP-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2)

MR204306L4 10 µg Ask for price

EBNA1BP2 (Myc-DDK-tagged)-Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2

RC200250 10 µg Ask for price

EBNA1BP2 (Myc-DDK-tagged)-Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 1

RC228292 10 µg Ask for price

EBV antigen EBNA-1 Antibody

abx140258-01mg 0.1 mg
EUR 393.6

Lenti ORF clone of Ebna1bp2 (Myc-DDK-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2)

MR204306L3 10 µg Ask for price

EBNA1-IN-SC7

T62921-10mg 10mg Ask for price
Description: EBNA1-IN-SC7

EBNA1-IN-SC7

T62921-1g 1g Ask for price
Description: EBNA1-IN-SC7

EBNA1-IN-SC7

T62921-1mg 1mg Ask for price
Description: EBNA1-IN-SC7

EBNA1-IN-SC7

T62921-50mg 50mg Ask for price
Description: EBNA1-IN-SC7

EBNA1-IN-SC7

T62921-5mg 5mg Ask for price
Description: EBNA1-IN-SC7

EBNA1 binding protein 2 (EBNA1BP2) (C-term) rabbit polyclonal antibody, Aff - Purified

AP51355PU-N 400 µl Ask for price

pCXWB- EBNA1 Plasmid

PVT7175 2 ug
EUR 319.2

Lenti ORF clone of Ebna1bp2 (mGFP-tagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), (10 ug)

RR214064L4 10 µg Ask for price

Lenti ORF clone of Ebna1bp2 (Myc-DDK-tagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), (10 ug)

RR214064L3 10 µg Ask for price

Lenti ORF particles, Ebna1bp2 (GFP-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2), 200ul, >10^7 TU/mL

MR204306L4V 200 µl Ask for price

Lenti ORF particles, Ebna1bp2 (GFP-tagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), 200ul, >10^7 TU/mL

RR214064L4V 200 µl Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, mGFP tagged

RC200250L2 10 µg Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, mGFP tagged

RC200250L4 10 µg Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 1, mGFP tagged

RC228292L4 10 µg Ask for price

Lenti ORF particles, Ebna1bp2 (Myc-DDK-tagged) - Mouse EBNA1 binding protein 2 (Ebna1bp2), 200ul, >10^7 TU/mL

MR204306L3V 200 µl Ask for price

EBNA1 (RFP-Bsd) Lentivirus

LVP1134-RB 1x107 IFU/ml x 200ul
EUR 418.8
Description: Premade lentivirus expressing Epstein Barr Virus' EBNA1 gene under EF1a promoter, containing RFP-Blasticidin dual marker.

EBNA1 (GFP-Puro) Lentivirus

LVP1134-GP 1x107 IFU/ml x 200ul
EUR 418.8
Description: Premade lentivirus expressing Epstein Barr Virus' EBNA1 gene under EF1a promoter, containing GFP-Puromycin dual marker.

Lenti ORF particles, Ebna1bp2 (Myc-DDK-tagged ORF) - Rat EBNA1 binding protein 2 (Ebna1bp2), 200ul, >10^7 TU/mL

RR214064L3V 200 µl Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, Myc-DDK-tagged

RC200250L1 10 µg Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, Myc-DDK-tagged

RC200250L3 10 µg Ask for price

3`UTR clone of EBNA1 binding protein 2 (EBNA1BP2) transcript variant 1 for miRNA target validation

SC203577 10 µg Ask for price

3`UTR clone of EBNA1 binding protein 2 (EBNA1BP2) transcript variant 2 for miRNA target validation

SC203579 10 µg Ask for price

Lenti ORF clone of Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 1, Myc-DDK-tagged

RC228292L3 10 µg Ask for price

OAEE00388-100UG - EBNA1 Antibody

OAEE00388-100UG 0.1mg
EUR 169

Lenti ORF particles, EBNA1BP2 (mGFP-tagged) - Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, 200ul, >10^7 TU/mL

RC200250L2V 200 µl Ask for price

Lenti ORF particles, EBNA1BP2 (mGFP-tagged) - Human EBNA1 binding protein 2 (EBNA1BP2), transcript variant 2, 200ul, >10^7 TU/mL

RC200250L4V 200 µl Ask for price